|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, Atlanta, Georgia 30322; 2 St. Vincent's Institute of Medical Research, St. Vincent's Hospital, Fitzroy, Victoria 3065, Australia; and 3 Department of Pharmacology, Rush Presbyterian St. Luke's Medical Center, Chicago, Illinois 60612
| |
ABSTRACT |
|---|
|
|
|---|
Shear stress stimulates nitric oxide (NO) production by phosphorylating endothelial NO synthase (eNOS) at Ser1179 in a phosphoinositide-3-kinase (PI3K)- and protein kinase A (PKA)-dependent manner. The eNOS has additional potential phosphorylation sites, including Ser116, Thr497, and Ser635. Here, we studied these potential phosphorylation sites in response to shear, vascular endothelial growth factor (VEGF), and 8-bromocAMP (8-BRcAMP) in bovine aortic endothelial cells (BAEC). All three stimuli induced phosphorylation of eNOS at Ser635, which was consistently slower than that at Ser1179. Thr497 was rapidly dephosphorylated by 8-BRcAMP but not by shear and VEGF. None of the stimuli phosphorylated Ser116. Whereas shear-stimulated Ser635 phosphorylation was not affected by phosphoinositide-3-kinase inhibitors wortmannin and LY-294002, it was blocked by either treating the cells with a PKA inhibitor H89 or infecting them with a recombinant adenovirus-expressing PKA inhibitor. These results suggest that shear stress stimulates eNOS by two different mechanisms: 1) PKA- and PI3K-dependent and 2) PKA-dependent but PI3K-independent pathways. Phosphorylation of Ser635 may play an important role in chronic regulation of eNOS in response to mechanical and humoral stimuli.
endothelial cells; vascular endothelial growth factor; cAMP
| |
INTRODUCTION |
|---|
|
|
|---|
NITRIC OXIDE (NO) produced from endothelial nitric oxide synthase (eNOS) plays critical roles in normal vascular biology and pathophysiology. In addition to its well-known vascular functions such as vessel relaxation and inhibition of platelet aggregation, NO also inhibits some of the key steps in atherogenesis, including cell death and monocyte adhesion induced by proatherogenic factors (14, 15, 24, 45). NO production from eNOS is stimulated by a variety of mechanical forces such as shear stress and stretching, and humoral factors ranging from growth factors and peptide hormones such as vascular endothelial growth factor (VEGF), estrogen, sphingosine-1-phosphate, acetylcholine, and bradykinin (13, 17, 18, 25, 36, 37).
The eNOS is known as a Ca2+/calmodulin (CaM)-dependent form of NOS (34). Indeed, most humoral ligands including bradykinin, acetylcholine, and ATP stimulate NO production from eNOS by raising the level of intracellular Ca2+, which forms Ca2+/CaM complex (34). On the other hand, mechanical forces such as fluid shear stress and stretching stimulate NO production from eNOS by Ca2+-independent mechanisms (1, 10). Moreover, eNOS has been shown to be regulated by interactions with other positive and negative protein modulators such as caveolin and heat shock protein 90 (20, 41). In the basal state, the majority of eNOS appears to be bound to caveolin-1 with its enzyme activity repressed in the caveolae (27, 33). This tonic inhibition of eNOS can be released by displacing caveolin-1 with Ca2+/CaM in response to Ca2+-mobilizing agonists (27).
In addition to those modulators, phosphorylation of eNOS at key regulatory sites plays an important role in regulation of enzyme activity in response to several physiological stimuli (3, 13, 17, 23, 35). It has been shown that phosphorylation of eNOS-Ser1179 (based on bovine eNOS sequence and equivalent to human eNOS-Ser1177) is associated with increased activity of the enzyme (19, 32). Phosphorylation of eNOS-Ser1179 is regulated by phophosinositide-3-kinase (PI3K)-dependent mechanisms (19). Akt, one of the major regulatory targets of PI3K, has been shown to directly phosphorylate eNOS at Ser1179 and activate the enzyme in response to vascular endothelial growth factor (VEGF), sphingosine-1-phosphate, and estrogen (13, 17, 25, 36, 37). However eNOS-Ser1179 can also be phosphorylated by AMP-activated protein kinase (8), or protein kinase A (PKA), and protein kinase G (PKG) (5). Exactly which protein kinase(s) phosphorylates eNOS-Ser1179 in intact cells appears to be regulated by the cellular context and given stimuli. For example, we have shown that shear stress phosphorylates eNOS-Ser1179 by a PI3K- and PKA-dependent manner without involving Akt, whereas VEGF phosphorylates eNOS-Ser1179 by a PI3K- and Akt-dependent manner (3, 21).
Phosphorylation of eNOS at Thr497 has also been shown to play an essential role in the regulation of enzyme activity (8, 23, 35, 36). For example, bradykinin has been shown to stimulate NO production by a mechanism involving dephosphorylation at Thr497 (23).
In addition to Ser1179 and Thr497, eNOS has several other potential phosphorylation sites, including Ser116, Ser635 (13, 17, 19, 35, 36), and some unknown sites (2, 19). Differential phosphorylation of eNOS at various sites could play an important role in the regulation of enzyme activity. However, little information is available regarding their phosphorylation in response to various stimuli. In the present study, we systematically compared phosphorylation of eNOS at Ser116, Thr497, Ser635, and Ser1179 in response to shear stress, VEGF, and cAMP. The current study, for the first time, demonstrates that phosphorylation eNOS-Ser635 was stimulated by shear stress, VEGF, and cAMP. More interestingly, we show evidence that shear-dependent phosphorylation of eNOS-Ser635 is regulated by a different mechanism from that of eNOS-Ser1179.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cell culture. Bovine aortic endothelial cells (BAEC) harvested from descending thoracic aortas were maintained (37°C, 5% CO2) in a growth medium [Dulbecco's modified Eagle's medium (DMEM) containing 1 g/l glucose (GIBCO) and 20% fetal bovine serum (FBS, Atlanta Biologicals) without antibiotics] (26). BAEC used in this study were between passages 5 and 10. Unless specified otherwise, 2 million cells were seeded in 100-mm tissue culture dishes (Falcon) and grown to confluency in the growth medium before exposure to stimuli.
Adenoviral infections. For the infection of BAEC with recombinant adenovirus, 1 million cells were seeded in 100-mm tissue culture dishes (Falcon) 1 day before infection. Cells were infected with recombinant adenovirus at 100 multiplicity of infection in serum-free DMEM for 1 h and then incubated 48 h in a growth medium before the treatment. Construction of the recombinant adenovirus encoding PKA inhibitor (Ad-PKI) has been described previously (30). Recombinant adenovirus encoding green fluorescence protein (Ad-GFP) was used as a control.
Shear stress studies. A confluent monolayer of BAEC grown in a 100-mm dish was exposed to nonpulsatile, laminar shear stress in a shear medium (phenol red-free DMEM containing 0.5% FBS and 25 mM HEPES, pH 7.4) by rotating a Teflon cone (0.5° cone angle) as we described previously (21, 43). Cells were exposed to an arterial level of shear stress (15 dyn/cm2) (3, 21).
Preparation of cell lysates.
After experimental treatments, cells were washed in ice-cold
phosphate-buffered saline (PBS) and lysed in 0.75 ml lysis buffer A (20 mM Tris · HCl, pH 7.6, 150 mM NaCl, 1 mM EDTA, 1 mM
EGTA, 2.5 mM sodium pyrophosphate, 1 mM
-glycerophosphate, 1 mM
sodium vanadate, 1 µg/ml leupeptin, 1 mM phenylenemethylsulfonyl
fluoride, 1 µM microcystin, and 1% Triton X-100). Cell lysates were
clarified by spinning at 14,000 g for 15 min at 4°C.
Protein content of each sample was measured by using a Bio-Rad DC assay
(26).
Immunoblotting. Aliquots of cell lysates (20 µg protein each) were resolved on a 10% SDS-PAGE gel and transferred to a polyvinylidene difluoride membrane (Millipore) (26). The membrane was incubated with a primary antibody overnight at 4°C and then with a secondary antibody conjugated with alkaline phosphatases (1 h at room temperature), which were detected by a chemiluminescence method (26). The intensities of immunoreactive bands in Western blots were analyzed by using the NIH Image program. The following primary antibodies were used: polyclonal antibodies for phosphorylated forms of Akt-Thr308, Akt-Ser473, and eNOS-Ser1179; a monoclonal antibody for phosphorylated form of cAMP response element binding (CREB) protein (CREB-Ser133); a polyclonal antibody for total CREB from Cell Signaling Technology; and a polyclonal antibody for total Akt from Santa Cruz biotechnology; polyclonal and monoclonal antibodies for total eNOS from Transduction Laboratories. Rabbit polyclonal antibodies specific for phosphorylated forms of eNOS-Ser116, eNOS-Thr497, and eNOS-Ser635, respectively, were raised and purified as previously described (8).
Statistical analysis. Statistical analysis was performed by Student's t-test. The P < 0.05 based on at least three or more independent experiments was considered to be statistically significant.
| |
RESULTS |
|---|
|
|
|---|
Differential phosphorylation of eNOS at Ser116,
Thr497, Ser635, and Ser1179 in
response to shear stress, VEGF, and cAMP.
To determine whether shear stress stimulates phosphorylation of eNOS at
amino acid residues other than the well-characterized Ser1179, Western blot studies were carried out using
antibodies specific to eNOS phosphorylated at Ser116,
Thr497, Ser635, and Ser1179,
respectively. As expected, exposure of BAEC to an arterial level of
laminar shear stress (15 dyn/cm2) stimulated
phosphorylation of eNOS-Ser1179 in a time-dependent manner
as shown previously (3). Phosphorylation of
eNOS-Ser1179 was apparent as early as 2 min after shear
onset, reached maximum by 30 min, and remained elevated at least
for 1 h (Fig.
1A).
|
|
Differential time course of Akt phosphorylation in response to shear stress, VEGF, and cAMP. Recently, we showed that shear stress stimulates phosphorylation of eNOS-Ser1179 in an Akt-independent manner, whereas VEGF phosphorylates eNOS-Ser1179 in an Akt-dependent manner (3). Therefore, we compared the activation patterns of Akt by monitoring phosphorylation at two major regulatory sites, Thr308 and Ser473. As shown in Fig. 2B, shear stress stimulated Akt phosphorylation in a time-dependent manner, reaching maximum on 30-min shear exposure and remaining at maximum for at least 1 h. In contrast, VEGF stimulated Akt phosphorylation rapidly (maximum within 2-5 min) and in a transient manner (returning to a basal level by 15 min) (Fig. 2C). Unlike shear stress and VEGF, 8-BRcAMP is a relatively weak and slow activator of Akt (Fig. 2D). Any discernible changes in Akt phosphorylation by 8-BRcAMP required at least 15 min and remained stimulated by twofold for up to 1 h.
It is noteworthy that treatment of BAEC with 8-BRcAMP induced phosphorylation of eNOS-Ser1179 in >2 min, whereas Akt phosphorylation required more than 15 min of exposure (compare Fig. 1C and 2D). This result provides additional evidence that eNOS-Ser1179 can be phosphorylated in the absence of Akt activation if cells are activated by PKA-dependent mechanisms.Shear stress regulates phosphorylation of eNOS-Ser635
in a PI3K-independent manner.
We then determined whether phosphorylation of eNOS-Ser635
by shear stress is regulated in a PI3K-dependent manner. For this
study, BAEC were pretreated for 30 min with two structurally distinct PI3K inhibitors, wortmannin and LY-294002, and then exposed to shear
stress for 30 min. As expected, treatment of BAEC with either wortmannin or LY-294002 inhibited eNOS-Ser1179
phosphorylation as well as Akt phosphorylation (Fig.
3, A and B).
However, the eNOS-Ser635 phosphorylation stimulated by
shear stress was not affected by either inhibitor (Fig. 3, A
and B). This result suggests that shear-dependent
phosphorylation of eNOS-Ser635 is regulated by a
PI3K-independent mechanism.
|
Shear stress stimulates phosphorylation of eNOS-Ser635
in a PKA-dependent manner.
The 8-BRcAMP effect shown above (Fig. 3C) suggested a role
of PKA in the phosphorylation of eNOS-Ser635 in response to
shear stress. To examine this further, PKA was inhibited either by
treating cells with a pharmacological inhibitor H89 or by expressing
PKI in cells by using an adenoviral construct Ad-PKI. Treatment of BAEC
with H89 for 30 min inhibited shear-induced phosphorylation of
eNOS-Ser635 (Fig.
4A). Under the same
conditions, shear-dependent phosphorylation of eNOS-Ser1179
was also inhibited, but Akt phosphorylation was further enhanced by H89
(Fig. 4A) as shown previously (3).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The most significant finding reported in the current study is that eNOS is phosphorylated at Ser635 in response to mechanical (shear stress) and humoral (VEGF and cAMP) stimuli. We also report evidence supporting that shear-dependent phosphorylation of eNOS-Ser635 is regulated in a PKA-dependent but PI3K-independent manner. In addition, we found that two other potential phosphorylation sites of eNOS at Thr497 and Ser116 were not regulated by shear stress or VEGF. However, cAMP induced a rapid dephosphorylation of Thr497.
It has been well documented that phosphorylation of eNOS-Ser1179 plays a key role in stimulation of eNOS activity in response to various physiological stimuli, which activate eNOS in a Ca2+-independent manner, including shear stress, VEGF, and estrogen (3, 12, 17, 21, 25). Other stimuli that activate eNOS by Ca2+-dependent mechanisms may not require phosphorylation. For example, although bradykinin stimulates phosphorylation of eNOS-Ser1179, it does not appear to have any regulatory role in eNOS activation (23).
Recent studies including our own work have shown that phosphorylation of eNOS-Ser1179 is mediated by a PI3K-dependent mechanism. However, it is not likely that PI3K directly phosphorylates eNOS-Ser1179. Instead it is highly likely that PI3K leads to activation of PDK1, and PDK1 in turn stimulates downstream target protein kinases, including Akt, PKA, PKG, and AMP kinase, which directly phosphorylate eNOS (3, 5, 13, 17, 35). PDK1 has been shown to activate, not only the well-known Akt, but also other protein kinases such as PKA, PKG, PKC, serum- and glucocorticoid-inducible kinase, and p70S6 kinase (9, 44). Whether the PI3K/PDK1 pathway indeed regulates these other protein kinases in response to a particular stimulus remains to be determined. At present it is not known whether AMP kinase can also be activated in a PI3K-dependent manner. Which protein kinase phosphorylates eNOS-Ser1179 appears to be determined by each given stimulus. For example, we showed that shear stress stimulates phosphorylation of eNOS-Ser1179 by PKA-dependent but Akt-independent mechanisms (3). An earlier study (13) suggested that shear stimulates eNOS-Ser1179 phosphorylation by the Akt-dependent mechanisms. This notion was based on indirect studies using mainly PI3K inhibitors and overexpression of constitutively active Akt mutants. However, the use of dominant negative mutants as performed more recently by Boo et al. (3) directly demonstrated that Akt is not the protein kinase-regulating eNOS-Ser1179 phosphorylation in response to shear stress. On the other hand, the same study confirmed that VEGF stimulates phosphorylation of eNOS-Ser1179 by Akt-dependent mechanisms (3).
Although it is clear that eNOS-Ser1179 is one of the key regulatory sites in response to shear stress and VEGF, eNOS contains many other potential phosphorylation sites, including Ser116, Thr497, and Ser635 (18). Therefore, we examined whether shear stress regulates phosphorylation of these potential sites by taking advantage of the phosphorylation site-specific eNOS antibodies.
Using phosphorylation of eNOS-Ser1179 in response to shear stress as a positive control and reference, we compared phosphorylation patterns of Ser116, Thr497, Ser635, and Ser1179 in response to shear stress, VEGF, and cAMP. First, eNOS-Ser1179 was phosphorylated by all three stimuli with unique time courses. Shear stress stimulated phosphorylation of eNOS-Ser1179 gradually and relatively slowly reaching maximum by 30-60 min exposure (Fig. 1A). On the other hand, both VEGF and cAMP rapidly stimulated phosphorylation of eNOS-Ser1179 reaching maximum levels within 2 min exposure (Fig. 1, B and C). Interestingly, VEGF-dependent phosphorylation of Ser1179 was transient returning to a basal level by 15 min exposure, whereas the maximal phosphorylation of Ser1179 induced by cAMP was maintained for as long as 1 h (Fig. 1C).
Currently, it is not known why VEGF-dependent phosphorylation of eNOS-Ser1179 is transient, whereas those induced by either shear stress or cAMP remain elevated for a longer period. One potential mechanism underlying different response patterns of eNOS-Ser1179 phosphorylation may be related to the upstream kinases Akt and PKA. Consistent with this possibility, the VEGF-dependent phosphorylation of Akt was indeed transient reaching maximum by 2-5 min and returning to a basal level by 15 min treatment (Fig. 2C). In comparison, the maximum phosphorylation of eNOS-Ser1179 induced by cAMP occurred (within 2 min) before there was any sign of Akt phosphorylation (requires at least 15 min) (Fig. 1C and 2D). In addition, phosphorylation of eNOS-Ser1179 induced by either shear stress or cAMP was prevented by PKA inhibitor H89 or Ad-PKI, further supporting the role of PKA, as shown previously (3).
We then found no evidence that the phosphorylation status of eNOS-Ser116 is regulated in response to shear stress, VEGF, or cAMP. However the Ser116 site was reported to be phosphorylated in response to shear stress in BAEC as determined by mass spectroscopy (19). Although the exact reasons are not clear, there are subtle differences in experimental conditions that could have contributed to the discrepancy between the two studies. The presence or absence of NaVO3 in the shear media and confluency of endothelial cells used for shear studies appear to be especially relevant. For example, in the study by Gallis et al. (19) study subconfluent (60-80% confluency) BAEC were labeled with [32P]orthophosphate in the presence of 200 µM NaVO3 in DMEM supplemented with 10% serum. In comparison, our studies were carried out using confluent BAEC monolayers in serum-deficient medium (DMEM containing 0.5% serum) in the absence of NaVO3.
The eNOS-Thr497 was rapidly dephosphorylated when BAEC were treated with 8-BRcAMP (Fig. 1A). In contrast, shear stress and VEGF did not have any effect on the phosphorylation status of eNOS-Thr497 (Fig. 1A). 8-BRcAMP-induced dephosphorylation of Thr497 was consistent with a previous finding by using an independent approach with isobutyl methylxanthine to increase the cellular cAMP level (35). Unlike in BAEC, however, VEGF stimulated dephosphorylation of eNOS-Thr497 in endothelial cells obtained from a different vascular bed, human umbilical vein endothelial cells (35). These differences in the behavior of endothelial cells depending on vascular origin are not unusual (28, 40). These results also provide an example that the response of cells to a physiological stimulus such as shear stress and VEGF are not necessarily identical compared with that induced by a bolus addition of 8-BRcAMP. It is possible that PKA activation induced by the physiological stimuli may be more restricted thus ensuring signaling specificity, whereas a bolus addition of 8-BRcAMP could activate many PKA isoforms regardless of their subcellular locations or cellular context. These results do not support a role for phosphorylation/dephosphorylation of eNOS-Thr497 in shear stress-dependent activation of eNOS.
We found in this study that shear stress, as well as VEGF and 8-BRcAMP,
stimulate phosphorylation of eNOS-Ser635 (Fig.
1B). As far as we are aware, this is the first demonstration of eNOS-Ser635 phosphorylation under physiologically
relevant stimuli. It is interesting to note that phosphorylation of
eNOS-Ser635 is consistently slower than that of
eNOS-Ser1179 in response to all three stimuli (Fig. 1).
This raises the possibility that phosphorylation of Ser1179
may prime Ser635 for a subsequent phosphorylation. This
possibility was further supported by the data showing that PKA
inhibition by H89 or Ad-PKI blocked phosphorylation of both
eNOS-Ser1179 and Ser635 (Fig. 4 and
5A). One simple interpretation of this result was that PKA
might phosphorylate both sites at Ser1179 and
Ser635 in a sequential manner. However, this speculation
was not supported by subsequent experiments using PI3K inhibitors
wortmannin and LY-294002 because both inhibitors blocked
phosphorylation of Ser1179 but not of Ser635
(Fig. 3). If the Ser1179 phosphorylation was a prerequisite
step, wortmannin or LY-294002 should have blocked phosphorylation of
Ser635 as well. However, that was not the case. An
alternative mechanism is that shear stress may stimulate two
independent signaling pathways: one that activates a PI3K-dependent PKA
pathway phosphorylating eNOS-Ser1179 and another that
activates a PI3K-independent PKA pathway phosphorylating eNOS-Ser635 (Fig. 6). This
scenario, however, would require the presence of at least two different
pools of PKA.
|
One potential support for this speculation regarding two different
pools of PKA is the preferential subcellular localization of different
isoforms of PKA (4). PKA is a tetramer composed of two
regulatory (R) and two catalytic (C) subunits. The mammalian PKA family
includes four types of R subunits (RI
, RI
, RII
, and RII
)
and two C subunits (C
and C
) (4). Whereas RI types tend to be found in the cytosolic fraction of cells, RII subunits have
been found to be associated with particulate fractions
(4).
A typical activation of PKA occurs when cAMP binds to the R subunit thereby releasing the C subunit and leading to activation of the released C subunit. However, it has been previously shown that shear stress does not affect cAMP level in endothelial cells (31). Then, how would PKA be activated by shear stress without changing total cAMP levels?
Accumulating evidence suggest that PKA can be regulated in a
cAMP-independent manner. One mechanism is phosphorylation of Thr197 in the activation loop of C subunit by PDK1
(6, 9). Other mechanisms include interactions of PKA with
caveolin, A-kinase-anchoring protein (AKAP110), and inhibitory nuclear
factor
B (I
B) protein (16, 39, 42). It is especially
interesting that the phosphorylation of the key regulatory site
Thr197 is mediated by PDK1 (9) because shear
stress has been shown to stimulate PI3K (22), which in
turn activates PDK1. We speculate that shear stress activates PKA
through a PI3K-PDK1 pathway and then PKA phosphorylates
eNOS-Ser1179 either directly or indirectly (Fig. 6).
The sequence surrounding Thr197 matches the consensus PDK1
phosphorylation sequence and is conserved in both PKA catalytic
subunits C
and C
(46). Therefore, once PDK1 is
activated, it is likely to activate both isoforms if they were in the
close vicinity. However, PDK1 is believed to be localized in the plasma
membrane, and it may not be able to phosphorylate those PKAs that are
not colocalized. Because shear-dependent phosphorylation of
eNOS-Ser635 was not prevented by PI3K inhibitors, it is
unlikely that the PKA phosphorylating this site is a PI3K/PDK-dependent
isoform. Therefore, we propose that PKA is activated in a
compartmentalized and time-dependent manner in response to shear stress.
What is the physiological significance of phosphorylation of eNOS? Whereas the importance of eNOS-Ser1179 and Thr497 has been explored, the role of Ser635 is unknown at this point. The eNOS is composed of two identical monomers and each monomer contains the amino-terminal oxidase domain and carboxy-terminal reductase domain (18). To produce NO from substrates O2 and L-arginine, electron flux has to occur from the reductase domain of one monomer to the oxygenase domain of the other monomer. Binding of Ca2+/CaM plays a key role in coupling the two monomers so that electron can be fluxed and, in turn, NO can be produced. It has been proposed that the carboxy-terminal tail of eNOS, including Ser1179 is "wedged" in between the two monomers and act as autoinhibitory domain by blocking electron transfer between the two monomers (29). Phosphorylation of Ser1179 upon challenge with eNOS stimulators is proposed to induce the conformation change of the carboxy-terminal, which removes the wedge and lowers Ca2+ requirement leading to enzyme activation (29, 32). eNOS-Thr497 is adjacent to the CaM-binding region, and its phosphorylation has been proposed to hamper CaM binding and prevent enzyme activation (8).
It was previously shown that mutation of eNOS-Ser635 to Ala (S635A) did not induce any changes in phosphorylation and activation of eNOS stimulated by Akt-dependent mechanisms (13, 17). Taken together with our current studies, these results support the concept that Ser635 is phosphorylated by an Akt-independent but PKA-dependent mechanism. In addition, another eNOS mutant (S635D) in which eNOS-Ser635 was mutated to Asp to mimic a continuously phosphorylated state showed the identical enzyme activity as that of wild-type eNOS in an in vitro assay using a saturating concentration of Ca2+ (13). However, it remains to be determined whether phosphorylation of eNOS-Ser635 would alter enzyme activity in cells as well as in enzyme assays using subsaturating levels of Ca2+.
It has been recognized that a ~50-residue segment present in the flavin mononucleotide -binding domain of eNOS (residue 596-647 based on the bovine sequence) represents a putative "autoinhibitory element" that impedes CaM binding to eNOS and electron flux between the two monomers (7, 38). Deletion of this element from eNOS decreases Ca2+ and CaM requirement for enzyme activation and enhances maximal activity (7, 38). Because Ser635 is located in this "autoinhibitory element," it is a reasonable speculation that phosphorylation of Ser635 may affect CaM binding and electron transfer of the enzyme. However, this speculation awaits further study.
In conclusion, we found that mechanical shear stress stimulates phosphorylation of eNOS at Ser635. In addition, VEGF also stimulates phosphorylation at the same site indicating that eNOS-Ser635 may be an important regulatory site in response to both mechanical and humoral stimuli. We also showed evidence supporting that shear-dependent phosphorylation of eNOS-Ser635 is regulated by PI3K-independent but PKA-dependent mechanisms. The slow time course suggests that phosphorylation of Ser635 is likely to play a role in a chronic regulation of eNOS activity rather than in the acute NO production phase within minutes of the agonist stimulation. For example, phosphorylation of eNOS-Ser635 may determine its subcellular localization and interaction with other cofactors and regulators of eNOS. These questions are interesting subjects for future studies.
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported by National Heart, Lung, and Blood Institute Grant HL-60905, National Aeronautics and Space Administration Grant NAG2-1348, and a Whitaker Development fund (to H. Jo).
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: H. Jo, Wallace H. Coulter Dept. of Biomedical Engineering at Georgia Tech and Emory Univ., 308D WMB, Atlanta, GA 30322 (E-mail: hanjoong.jo{at}bme.gatech.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
July 8, 2002;10.1152/ajpheart.00214.2002
Received 13 March 2002; accepted in final form 21 June 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Ayajiki, K,
Kindermann M,
Hecker M,
Fleming I,
and
Busse R.
Intracellular pH and tyrosine phosphorylation but not calcium determine shear stress-induced nitric oxide production in native endothelial cells.
Circ Res
78:
750-758,
1996
2.
Bernier, SG,
Haldar S,
and
Michel T.
Bradykinin-regulated interactions of the mitogen-activated protein kinase pathway with the endothelial nitric-oxide synthase.
J Biol Chem
275:
30707-30715,
2000
3.
Boo, YC,
Sorescu G,
Boyd N,
Shiojima I,
Walsh K,
Du J,
and
Jo H.
Shear stress stimulates phosphorylation of endothelial nitric-oxide synthase at Ser1179 by Akt-independent mechanisms: role of protein kinase A.
J Biol Chem
277:
3388-3396,
2002
4.
Brandon, EP,
Idzerda RL,
and
McKnight GS.
PKA isoforms, neural pathways, and behaviour: making the connection.
Curr Opin Neurobiol
7:
397-403,
1997[ISI][Medline].
5.
Butt, E,
Bernhardt M,
Smolenski A,
Kotsonis P,
Frohlich LG,
Sickmann A,
Meyer HE,
Lohmann SM,
and
Schmidt HH.
Endothelial nitric-oxide synthase (type III) is activated and becomes calcium independent upon phosphorylation by cyclic nucleotide-dependent protein kinases.
J Biol Chem
275:
5179-5187,
2000
6.
Cauthron, RD,
Carter KB,
Liauw S,
and
Steinberg RA.
Physiological phosphorylation of protein kinase A at Thr-197 is by a protein kinase A kinase.
Mol Cell Biol
18:
1416-1423,
1998
7.
Chen, PF,
and
Wu KK.
Characterization of the roles of the 594-645 region in human endothelial nitric-oxide synthase in regulating calmodulin binding and electron transfer.
J Biol Chem
275:
13155-13163,
2000
8.
Chen, ZP,
Mitchelhill KI,
Michell BJ,
Stapleton D,
Rodriguez-Crespo I,
Witters LA,
Power DA,
Ortiz de Montellano PR,
and
Kemp BE.
AMP-activated protein kinase phosphorylation of endothelial NO synthase.
FEBS Lett
443:
285-289,
1999[ISI][Medline].
9.
Cheng, X,
Ma Y,
Moore M,
Hemmings BA,
and
Taylor SS.
Phosphorylation and activation of cAMP-dependent protein kinase by phosphoinositide-dependent protein kinase.
Proc Natl Acad Sci USA
95:
9849-9854,
1998
10.
Corson, MA,
James NL,
Latta SE,
Nerem RM,
Berk BC,
and
Harrison DG.
Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress.
Circ Res
79:
984-991,
1996
11.
Daniel, PB,
Walker WH,
and
Habener JF.
Cyclic AMP signaling and gene regulation.
Annu Rev Nutr
18:
353-383,
1998[ISI][Medline].
12.
Dimmeler, S,
Assmus B,
Hermann C,
Haendeler J,
and
Zeiher AM.
Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: involvement in suppression of apoptosis.
Circ Res
83:
334-341,
1998
13.
Dimmeler, S,
Fleming I,
Fisslthaler B,
Hermann C,
Busse R,
and
Zeiher AM.
Activation of nitric oxide synthase in endothelial cells by Akt- dependent phosphorylation.
Nature
399:
601-605,
1999[Medline].
14.
Dimmeler, S,
Haendeler J,
Nehls M,
and
Zeiher AM.
Suppression of apoptosis by nitric oxide via inhibition of interleukin- 1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)- 32-like proteases.
J Exp Med
185:
601-607,
1997
15.
Dimmeler, S,
Hermann C,
Galle J,
and
Zeiher AM.
Upregulation of superoxide dismutase and nitric oxide synthase mediates the apoptosis-suppressive effects of shear stress on endothelial cells.
Arterioscler Thromb Vasc Biol
19:
656-664,
1999
16.
Dulin, NO,
Niu J,
Browning DD,
Ye RD,
and
Voyno-Yasenetskaya T.
Cyclic AMP-independent activation of protein kinase A by vasoactive peptides.
J Biol Chem
276:
20827-20830,
2001
17.
Fulton, D,
Gratton JP,
McCabe TJ,
Fontana J,
Fujio Y,
Walsh K,
Franke TF,
Papapetropoulos A,
and
Sessa WC.
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt.
Nature
399:
597-601,
1999[Medline].
18.
Fulton, D,
Gratton JP,
and
Sessa WC.
Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough?
J Pharmacol Exp Ther
299:
818-824,
2001
19.
Gallis, B,
Corthals GL,
Goodlett DR,
Ueba H,
Kim F,
Presnell SR,
Figeys D,
Harrison DG,
Berk BC,
Aebersold R,
and
Corson MA.
Identification of flow-dependent endothelial nitric-oxide synthase phosphorylation sites by mass spectrometry and regulation of phosphorylation and nitric oxide production by the phosphatidylinositol 3-kinase inhibitor LY294002.
J Biol Chem
274:
30101-30108,
1999
20.
Garcia-Cardena, G,
Fan R,
Shah V,
Sorrentino R,
Cirino G,
Papapetropoulos A,
and
Sessa WC.
Dynamic activation of endothelial nitric oxide synthase by Hsp90.
Nature
392:
821-824,
1998[Medline].
21.
Go, YM,
Boo YC,
Park H,
Maland MC,
Patel R,
Pritchard KA, Jr,
Fujio Y,
Walsh K,
Darley-Usmar V,
and
Jo H.
Protein kinase B/Akt activates c-Jun NH(2)-terminal kinase by increasing NO production in response to shear stress.
J Appl Physiol
91:
1574-1581,
2001
22.
Go, YM,
Park H,
Maland MC,
Darley-Usmar VM,
Stoyanov B,
Wetzker R,
and
Jo H.
Phosphatidylinositol 3-kinase gamma mediates shear stress-dependent activation of JNK in endothelial cells.
Am J Physiol Heart Circ Physiol
275:
H1898-H1904,
1998
23.
Harris, MB,
Ju H,
Venema VJ,
Liang H,
Zou R,
Michell BJ,
Chen ZP,
Kemp BE,
and
Venema RC.
Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation.
J Biol Chem
276:
16587-16591,
2001
24.
Hermann, C,
Zeiher AM,
and
Dimmeler S.
Shear stress inhibits H2O2-induced apoptosis of human endothelial cells by modulation of the glutathione redox cycle and nitric oxide synthase.
Arterioscler Thromb Vasc Biol
17:
3588-3592,
1997
25.
Hisamoto, K,
Ohmichi M,
Kurachi H,
Hayakawa J,
Kanda Y,
Nishio Y,
Adachi K,
Tasaka K,
Miyoshi E,
Fujiwara N,
Taniguchi N,
and
Murata Y.
Estrogen induces the akt-dependent activation of endothelial nitric- oxide synthase in vascular endothelial cells.
J Biol Chem
276:
3459-3467,
2001
26.
Jo, H,
Sipos K,
Go YM,
Law R,
Rong J,
and
McDonald JM.
Differential effect of shear stress on extracellular signal-regulated kinase and N-terminal Jun kinase in endothelial cells. Gi2- and Gbeta/gamma-dependent signaling pathways.
J Biol Chem
272:
1395-1401,
1997
27.
Ju, H,
Zou R,
Venema VJ,
and
Venema RC.
Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity.
J Biol Chem
272:
18522-18525,
1997
28.
Kuchan, MJ,
Jo H,
and
Frangos JA.
Role of G proteins in shear stress-mediated nitric oxide production by endothelial cells.
Am J Physiol Cell Physiol
267:
C753-C758,
1994
29.
Lane, P,
and
Gross SS.
Disabling a C-terminal autoinhibitory control element in endotelial NO synthase by phosphorylation provides a molecular explanation for activation of vascular NO synthesis by diverse physiological stimuli.
J Biol Chem
277:
19087-19094,
2002
30.
Lum, H,
Jaffe HA,
Schulz IT,
Masood A,
RayChaudhury A,
and
Green RD.
Expression of PKA inhibitor (PKI) gene abolishes cAMP-mediated protection to endothelial barrier dysfunction.
Am J Physiol Cell Physiol
277:
C580-C588,
1999
31.
Malek, AM,
Greene AL,
and
Izumo S.
Regulation of endothelin 1 gene by fluid shear stress is transcriptionally mediated and independent of protein kinase C and cAMP.
Proc Natl Acad Sci USA
90:
5999-6003,
1993
32.
McCabe, TJ,
Fulton D,
Roman LJ,
and
Sessa WC.
Enhanced electron flux and reduced calmodulin dissociation may explain "calcium-independent" eNOS activation by phosphorylation.
J Biol Chem
275:
6123-6128,
2000
33.
Michel, JB,
Feron O,
Sacks D,
and
Michel T.
Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin.
J Biol Chem
272:
15583-15586,
1997
34.
Michel, T,
and
Feron O.
Nitric oxide synthases: which, where, how, and why?
J Clin Invest
100:
2146-2152,
1997[ISI][Medline].
35.
Michell, BJ,
Chen Z,
Tiganis T,
Stapleton D,
Katsis F,
Power DA,
Sim AT,
and
Kemp BE.
Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase.
J Biol Chem
276:
17625-17628,
2001
36.
Michell, BJ,
Griffiths JE,
Mitchelhill KI,
Rodriguez-Crespo I,
Tiganis T,
Bozinovski S,
de Montellano PR,
Kemp BE,
and
Pearson RB.
The Akt kinase signals directly to endothelial nitric oxide synthase.
Curr Biol
9:
845-848,
1999[ISI][Medline].
37.
Morales-Ruiz, M,
Lee MJ,
Zollner S,
Gratton JP,
Scotland R,
Shiojima I,
Walsh K,
Hla T,
and
Sessa WC.
Sphingosine 1-phosphate activates akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells.
J Biol Chem
276:
19672-19677,
2001
38.
Nishida, CR,
and
Ortiz de Montellano PR.
Autoinhibition of endothelial nitric-oxide synthase. Identification of an electron transfer control element.
J Biol Chem
274:
14692-14698,
1999
39.
Niu, J,
Vaiskunaite R,
Suzuki N,
Kozasa T,
Carr DW,
Dulin N,
and
Voyno-Yasenetskaya TA.
Interaction of heterotrimeric G13 protein with an A-kinase-anchoring protein 110 (AKAP110) mediates cAMP-independent PKA activation.
Curr Biol
11:
1686-1690,
2001[ISI][Medline].
40.
Ohno, M,
Gibbons GH,
Dzau VJ,
and
Cooke JP.
Shear stress elevates endothelial cGMP. Role of a potassium channel and G protein coupling.
Circulation
88:
193-197,
1993
41.
Pritchard, KA, Jr,
Ackerman AW,
Gross ER,
Stepp DW,
Shi Y,
Fontana JT,
Baker JE,
and
Sessa WC.
Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric-oxide synthase.
J Biol Chem
276:
17621-17624,
2001
42.
Razani, B,
Rubin CS,
and
Lisanti MP.
Regulation of cAMP-mediated signal transduction via interaction of caveolins with the catalytic subunit of protein kinase A.
J Biol Chem
274:
26353-26360,
1999
43.
Rieder, MJ,
Carmona R,
Krieger JE,
Pritchard KA, Jr,
and
Greene AS.
Suppression of angiotensin-converting enzyme expression and activity by shear stress.
Circ Res
80:
312-319,
1997
44.
Toker, A,
and
Newton AC.
Cellular signaling: pivoting around PDK-1.
Cell
103:
185-188,
2000[ISI][Medline].
45.
Tsao, PS,
Buitrago R,
Chan JR,
and
Cooke JP.
Fluid flow inhibits endothelial adhesiveness. Nitric oxide and transcriptional regulation of VCAM-1.
Circulation
94:
1682-1689,
1996
46.
Uhler, MD,
Chrivia JC,
and
McKnight GS.
Evidence for a second isoform of the catalytic subunit of cAMP-dependent protein kinase.
J Biol Chem
261:
15360-15363,
1986
This article has been cited by other articles:
![]() |
L. E. Goldfinger, E. Tzima, R. Stockton, W. B. Kiosses, K. Kinbara, E. Tkachenko, E. Gutierrez, A. Groisman, P. Nguyen, S. Chien, et al. Localized {alpha}4 Integrin Phosphorylation Directs Shear Stress-Induced Endothelial Cell Alignment Circ. Res., July 18, 2008; 103(2): 177 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. I. Jones III, Z. Han, T. Presley, S. Varadharaj, J. L. Zweier, G. Ilangovan, and B. R. Alevriadou Endothelial cell respiration is affected by the oxygen tension during shear exposure: role of mitochondrial peroxynitrite Am J Physiol Cell Physiol, July 1, 2008; 295(1): C180 - C191. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Yalcin, P. Ulker, U. Yavuzer, H. J. Meiselman, and O. K. Baskurt Nitric oxide generation by endothelial cells exposed to shear stress in glass tubes perfused with red blood cell suspensions: role of aggregation Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2098 - H2105. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fulton, L. Ruan, S. G. Sood, C. Li, Q. Zhang, and R. C. Venema Agonist-Stimulated Endothelial Nitric Oxide Synthase Activation and Vascular Relaxation: Role of eNOS Phosphorylation at Tyr83 Circ. Res., February 29, 2008; 102(4): 497 - 504. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gkaliagkousi, J. Ritter, and A. Ferro Platelet-Derived Nitric Oxide Signaling and Regulation Circ. Res., September 28, 2007; 101(7): 654 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Dudzinski and T. Michel Life history of eNOS: Partners and pathways Cardiovasc Res, July 15, 2007; 75(2): 247 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Csiszar, N. Labinskyy, K. E. Smith, A. Rivera, E. N.T.P. Bakker, H. Jo, J. Gardner, Z. Orosz, and Z. Ungvari Downregulation of Bone Morphogenetic Protein 4 Expression in Coronary Arterial Endothelial Cells: Role of Shear Stress and the cAMP/Protein Kinase A Pathway Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 776 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Mazer, F. Briet, K. R. Blight, D. J. Stewart, M. Robb, Z. Wang, A. M. Harrington, W. Mak, X. Li, and G. M.T. Hare Increased cerebral and renal endothelial nitric oxide synthase gene expression after cardiopulmonary bypass in the rat J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 13 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Sun, T.-S. Lee, M. Zhu, C. Gu, Y. Wang, Y. Zhu, and J. Y-J. Shyy Statins Activate AMP-Activated Protein Kinase In Vitro and In Vivo Circulation, December 12, 2006; 114(24): 2655 - 2662. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Lee and D. L. Mykles Proteomics and signal transduction in the crustacean molting gland Integr. Comp. Biol., December 1, 2006; 46(6): 965 - 977. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yayama, H. Hiyoshi, D. Imazu, and H. Okamoto Angiotensin II Stimulates Endothelial NO Synthase Phosphorylation in Thoracic Aorta of Mice With Abdominal Aortic Banding Via Type 2 Receptor Hypertension, November 1, 2006; 48(5): 958 - 964. [Abstract] [Full Text] [PDF] |
||||
![]() |
|